MA

Mital Ashit Chandaria

Active Director Designated Partner DIN 10904296
DIN 10904296 First appointment Oct 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value •••• Premium profile

About Mital Ashit Chandaria

Data last updated:

Mital Ashit Chandaria is a Designated Partner at Inno Pharma Llp (since 2024). The company operates in Healthcare. Inno Pharma Llp reported revenue of ₹57.4 Lakh (FY 2022).

DIN 10904296
Primary Designation Designated Partner
Industry Healthcare
First Appointment 25 Oct 2024
Oldest Company Age 13 yrs
Largest company Inno Pharma Llp · ₹57.4 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Inno Pharma Llp AAB-5628
Designated Partner25 Oct 20242013₹57.4 Lakh (FY 2022)Active

Board colleagues of Mital Ashit Chandaria

NameDINCompanyDesignation
Dipal Sandip Trivedi06581385Inno Pharma LlpDesignated Partner
Pragnesh Parshotambhai Donga10728020Inno Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Inno Pharma Llp
Premium access

Shareholding and investment profile for Mital Ashit Chandaria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mital Ashit Chandaria

Mital Ashit Chandaria currently holds 1 directorship: Inno Pharma Llp (Designated Partner, since 25 Oct 2024, revenue ₹57.4 Lakh (FY 2022)).

Mital Ashit Chandaria was first appointed on 25 Oct 2024 as Designated Partner at Inno Pharma Llp.

The current boards of Mital Ashit Chandaria's companies include Dipal Sandip Trivedi (Inno Pharma Llp), Pragnesh Parshotambhai Donga (Inno Pharma Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available